NASDAQ:PPD PPD (PPD) Stock Price, News & Analysis → Trump conviction scandal exposed (From Porter & Company) (Ad) Free PPD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$47.28▼$47.2850-Day Range$47.10▼$47.4152-Week Range$31.54▼$47.41VolumeN/AAverage Volume1.91 million shsMarket Capitalization$16.61 billionP/E Ratio47.28Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get PPD alerts: Email Address Ad Paradigm PressDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. About PPD Stock (NASDAQ:PPD)PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.Read More Ad Paradigm PressDiscover How to Turn $10,000 into $1 MillionToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.That will slam shut June 25. PPD Stock News HeadlinesMay 29, 2024 | msn.comPampa Police execute 2 search warrants at establishments suspected of illegal gamblingMay 29, 2024 | msn.comWhat Causes A Positive Ppd? A Review By DoctorsMay 28, 2024 | msn.comFour Gunmen Killed Pedestrian In Philadelphia Ambush, Police SayMay 28, 2024 | msn.comLegislatura de Taiwán aprueba cambios considerados como afines a China y reduce poder del presidenteMay 28, 2024 | msn.comShein’s Quest to Win Over America Gets Stuck in U.S.-China TensionsMay 27, 2024 | msn.comLos Angeles Dodgers at New York Mets, ppd.May 27, 2024 | msn.comPPD: Madison man charged with trafficking fentanyl after traffic stopMay 25, 2024 | msn.comMan killed in overnight Portsmouth shooting on Dale DriveMay 24, 2024 | msn.comPineville police investigating fatal crash involving pedestrian from BallMay 23, 2024 | msn.comParents of woman killed in Cocke County officer-involved shooting file lawsuitMay 23, 2024 | msn.comHarnessing molecular pathways governed by key gene to enhance wheat yieldsMay 23, 2024 | msn.comBest Life: Beating baby bluesMay 23, 2024 | msn.comGene could unlock greater wheat yields for a growing populationMay 21, 2024 | yahoo.comPensacola’s Downtown Improvement Board, PPD to crack down on noise problemMay 20, 2024 | msn.comElderly Pensacola man caught in PPD sex sting takes plea deal for child solicitationMay 19, 2024 | msn.comI Became Addicted to Opioids After Birth Complications & Amid PPD: This Is My StoryMay 19, 2024 | msn.comStudy reveals alarming rates of postpartum depression among mothers in six countriesMay 19, 2024 | msn.com3 shot on Victory Boulevard in PortsmouthMay 19, 2024 | yahoo.comPPD: Three people shot on Victory Blvd.May 18, 2024 | msn.comGroups urge greater scrutiny of homeschooling systemMay 17, 2024 | msn.comSuspect Accused Of Stealing From Pleasanton Restaurant Tip Jars: PPDMay 17, 2024 | msn.comPlainview PD captures suspect involved in Thursday morning shootingMay 16, 2024 | yahoo.comPPD arrests six-time felon found with gun and body armorMay 15, 2024 | msn.comPueblo police officers save woman in crisis from bridgeMay 15, 2024 | msn.comMan arrested in connection to Pensacola nightclub shooting: PPDSee More Headlines Receive PPD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PPD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/27/2021Today6/15/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Commercial Physical Research Sub-IndustryN/A Current SymbolNASDAQ:PPD CUSIPN/A CIK1793294 Webwww.ppdi.com Phone910-251-0081FaxN/AEmployees26,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$1.00 Trailing P/E Ratio47.28 Forward P/E Ratio32.16 P/E Growth2.11Net Income$153.69 million Net Margins6.11% Pretax Margin7.31% Return on Equity-89.48% Return on Assets7.94% Debt Debt-to-Equity RatioN/A Current Ratio1.23 Quick Ratio1.23 Sales & Book Value Annual Sales$4.68 billion Price / Sales3.55 Cash Flow$1.99 per share Price / Cash Flow23.71 Book Value($1.21) per share Price / Book-39.07Miscellaneous Outstanding Shares351,395,000Free Float344,718,000Market Cap$16.61 billion OptionableNot Optionable Beta1.96 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. David S. Simmons (Age 56)Chairman & CEO Comp: $3.42MMr. Christopher G. Scully (Age 50)Exec. VP, CFO, Treasurer & Assistant Sec. Comp: $1MMr. William J. Sharbaugh (Age 58)Chief Operating Officer Comp: $1.12MMr. Anshul Thakral (Age 43)Exec. VP, Chief Commercial Officer & Pres of Evidera Comp: $1.13MDr. David Michael Johnston (Age 52)Exec. VP of Global Clinical Devel. Comp: $788.87kMr. Glen Donovan (Age 47)Chief Accounting Officer Mr. B. Judd Hartman (Age 57)Exec. VP & Chief Admin. Officer Ms. Tracy H. Krumme (Age 53)VP & Head of Investor Relations Ms. Julia James (Age 46)Exec. VP, Gen. Counsel & Sec. Mr. Ronald E. Garrow (Age 57)Exec. VP & Chief HR Officer More ExecutivesKey CompetitorsPRA Health SciencesNASDAQ:PRAHSyneos HealthNASDAQ:SYNHIQVIANYSE:IQVICON PublicNASDAQ:ICLRIncyteNASDAQ:INCYView All Competitors Should I Buy PPD Stock? PPD Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in PPD, Inc.: PPD, Inc. stock price has been steadily increasing, indicating positive market sentiment and potential for capital appreciation. PPD, Inc. recently announced a strategic partnership with a leading pharmaceutical company, which could lead to increased revenue and market opportunities. Analysts project strong earnings growth for PPD, Inc. in the upcoming quarters, reflecting a promising financial outlook for investors. PPD, Inc. has a solid track record of delivering innovative solutions in the healthcare sector, positioning the company for long-term success and growth. The company's recent expansion into emerging markets has opened up new revenue streams and diversified its business portfolio, reducing risk for investors. Cons Investors should be bearish about investing in PPD, Inc. for these reasons: PPD, Inc. faces intense competition in the healthcare industry, which could impact its market share and profitability. Regulatory changes in the healthcare sector may pose challenges for PPD, Inc., leading to increased compliance costs and operational hurdles. Fluctuations in global economic conditions could affect PPD, Inc.'s revenue and earnings, making it susceptible to market volatility. The company's high debt levels may limit its flexibility in pursuing growth opportunities and increase financial risk for investors. Investors should closely monitor PPD, Inc.'s research and development pipeline to assess the potential impact of any setbacks on the company's future performance. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, June 4, 2024. Please send any questions or comments about these PPD pros and cons to contact@marketbeat.com. PPD Stock Analysis - Frequently Asked Questions How were PPD's earnings last quarter? PPD, Inc. (NASDAQ:PPD) issued its quarterly earnings results on Wednesday, October, 27th. The company reported $0.43 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.05. The business had revenue of $1.56 billion for the quarter, compared to the consensus estimate of $1.41 billion. PPD had a net margin of 6.11% and a negative trailing twelve-month return on equity of 89.48%. The company's revenue for the quarter was up 26.5% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.15 earnings per share. What other stocks do shareholders of PPD own? Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), Salesforce (CRM), Pfizer (PFE), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), RTX (RTX) and Verizon Communications (VZ). When did PPD IPO? PPD (PPD) raised $1.5 billion in an initial public offering on Thursday, February 6th 2020. The company issued 60,000,000 shares at $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers. This page (NASDAQ:PPD) was last updated on 6/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredA Silent Invasion of AmericaThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredDouble-Threat Biotech Could Deliver Triple-Digit GainsMost investors haven't heard of this under-the-radar biotech... But it could emerge as one of the premier A...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PPD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PPD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.